Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial)

Vincent Chan,Peter Jüni,Marc Ruel,Natasha Dhingra,Kibar Yared,David A Latter ,C David Mazer ,F Victor Chu ,Michael Chu ,Wendy Tsang,Judith Elizabeth Hall ,Hwee Teoh,Kim A Connelly ,Kwan‐Leung Chan ,Thierry G Mesana ,Howard Leong‐Poi ,Kevin E Thorpe ,Benoit E De Varennes ,Adrian Quan,Subodh Verma

doi:10.1136/bmjopen-2016-015032

Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial)

Vincent Chan, Peter Jüni + Show 18 more

Open Access

PDF Available

https://doi.org/10.1136/bmjopen-2016-015032

Copy DOI

Export

Save

Cite

Journal: BMJ Open	Publication Date: May 1, 2017
Citations: 12	License type: open-access

Affiliation: University of Ottawa, St. Michael's Hospital, University of Toronto, The Scarborough Hospital, McMaster University, London Health Sciences Centre, Western University, University Health Network, Public Health Ontario, Royal Victoria Regional Health Centre, McGill University

#Mitral Repair #Leaflet Resection #Functional Mitral Stenosis #Leaflet Preservation #Readmission For Congestive Heart Failure #Treatment Of Severe Mitral Regurgitation #Major Adverse Event End Point #Mitral Valve Repair Strategy #Mitral Valve #Leaflet Coaptation Height

Abstract
Full-Text PDF
Similar Papers

Abstract

Listen

BackgroundThe gold-standard treatment of severe mitral regurgitation (MR) due to degenerative disease is valve repair, which is surgically performed with either a leaflet resection or leaflet preservation approach. Recent data...

Full Text

Published Version (Free)

View/Download pdf

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: BMJ Open

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial)